What's hot

View all perspectives
      📊 SIJ findings in PsA (n=581):
      🧠 31% = MRI-confirmed axSpA
      🦴 Only 29% met r-mNY criteria
      MRI-axPsA group: young

      Jiha Lee JihaRheum

      3 months ago
      📊 SIJ findings in PsA (n=581): 🧠 31% = MRI-confirmed axSpA 🦴 Only 29% met r-mNY criteria MRI-axPsA group: younger, more male, HLA-B27+ Clinical + radiographic definitely underperform vs MRI #POS0297 @RheumNow #EULAR2025
      PsO + recent arthralgia—but no PsA. Treat or wait?
      🧠 18% developed PsA in 3 yrs, most in year 1
      🔍 Predictors: te

      Jiha Lee JihaRheum

      3 months ago
      PsO + recent arthralgia—but no PsA. Treat or wait? 🧠 18% developed PsA in 3 yrs, most in year 1 🔍 Predictors: tender joints, disability, enthesis erosion Consider early rheum input for these patients Abstract POS0299 @RheumNow #EULAR2025
      Can RZB deliver in real-world early PsA?
      💥 9-month results say yes:
      ✅ Dactylitis gone in 79%
      ✅ Enthesitis in 90%

      Jiha Lee JihaRheum

      3 months ago
      Can RZB deliver in real-world early PsA? 💥 9-month results say yes: ✅ Dactylitis gone in 79% ✅ Enthesitis in 90% ✅ 97% MDs & 88% pts satisfied Early intervention may pay off. Abstract POS0304 @RheumNow #EULAR2025
      Very pleased to present at #EULAR2025 work @ArthritisAust on consumer involvement into research.

      Consumer involvement i

      David Liew drdavidliew

      3 months ago
      Very pleased to present at #EULAR2025 work @ArthritisAust on consumer involvement into research. Consumer involvement in research delivers: - better, more relevant research - better dissemination of results - competitiveness in today’s funding landscape POS1016-PARE @RheumNow https://t.co/0fhpsnGhdT
      High dose NSAIDs and incidence of HTN in axSpA?

      In pts with early axSpA(age at baseline 33.2 years) data from DESIR coh

      Adela Castro AdelaCastro222

      3 months ago
      High dose NSAIDs and incidence of HTN in axSpA? In pts with early axSpA(age at baseline 33.2 years) data from DESIR cohort showed that after adjusting for confounders,high dose NSAID use was not associated with incident hypertension (HR 1.01, 95% CI 0.98-1.02). Interesting to
      Rheumatoid nodules are fascinating. If methotrexate nodulosis is a factor, why has their rate gone down when MTX use has

      David Liew drdavidliew

      3 months ago
      Rheumatoid nodules are fascinating. If methotrexate nodulosis is a factor, why has their rate gone down when MTX use has gone up? Environmental factors? Something else? It’s still a bit of a mystery - we still don’t know why Christopher Edwards #EULAR2025 @RheumNow https://t.co/8LJYNRybve
      Maybe the pathogenesis gives us a clue on how to target things?

      Possibly the treatments which take down synovitis might

      David Liew drdavidliew

      3 months ago
      Maybe the pathogenesis gives us a clue on how to target things? Possibly the treatments which take down synovitis might not always help with nodules Christopher Edwards #EULAR2025 @RheumNow https://t.co/T6QHCS8709
      #EULAR2025 Abstr#POS0320 Data from TULIP+LTE compared to Lupus Toronto Cohort as Control showed Anifrolumab reduced orga

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 months ago
      #EULAR2025 Abstr#POS0320 Data from TULIP+LTE compared to Lupus Toronto Cohort as Control showed Anifrolumab reduced organ damage progression up to 4 years vs real-world SOC in #SLE. Effect continued to 10yrs using novel extrapolate analysis @RheumNow https://t.co/bkjZCZ8xGr
      What is new in SpA?
      ‼️nomenclature change:
      🚫AS≠ Ankylosing spondylitis
      ✅AS= Axial spondyloarthritis

      -Helena

      Adela Castro AdelaCastro222

      3 months ago
      What is new in SpA? ‼️nomenclature change: 🚫AS≠ Ankylosing spondylitis ✅AS= Axial spondyloarthritis -Helena Marzo-Ortega at #EULAR2025 @RheumNow
      Delay hurts.
      Dx delay in axial SpA costs UK £3.1 billion annually.
      Avg time to dx = 8.5 yrs
      Avg dx cost = £187k/person

      Jiha Lee JihaRheum

      3 months ago
      Delay hurts. Dx delay in axial SpA costs UK £3.1 billion annually. Avg time to dx = 8.5 yrs Avg dx cost = £187k/person Fixing delay could save £167k/person. Early Dx isn’t just better care—it’s economic policy. #EULAR2025 @RheumNow #AxialSpA #RMD https://t.co/eYEQ2rp94m
      @RheumNow So rheumatoid nodule treatment might target some of that pathophysiology. Rituximab, abatacept, or JAKi?

      And

      David Liew drdavidliew

      3 months ago
      @RheumNow So rheumatoid nodule treatment might target some of that pathophysiology. Rituximab, abatacept, or JAKi? And while surgery often isn’t great (plus they often grow back), definitely an option for some. Christopher Edwards #EULAR2025 @RheumNow https://t.co/sFWnQN8uC4
      #Psoriatic_Arthritis
      #Preclinical #Early

      ❓️ Does joint swelling occur in the same anatomical locations affected in

      Nelly ZIADE 🍀 Nellziade

      3 months ago
      #Psoriatic_Arthritis #Preclinical #Early ❓️ Does joint swelling occur in the same anatomical locations affected in the subclinical phase? 🅰️ Yes, in 68% 🅰️ Especially if positive ultrasound #EULAR2025 @RheumNow OP0179 by Ivan Giivannini et al. https://t.co/rKfreQyJeG
      #EULAR2025 Abstr#POS0321 In addition to complete renal response attainment as you already know, exploratory analysis fro

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 months ago
      #EULAR2025 Abstr#POS0321 In addition to complete renal response attainment as you already know, exploratory analysis from REGENCY showed Obinutuzumab+SOC reduced #lupus nephritis flare and unfavourable kidney outcomes vs PBO+SOC. Longterm kidney survival protection @RheumNow https://t.co/vRFb94TXaQ
      Rheumatoid vasculitis: what to look for and how to find it
      #EULAR2025 @AshimaMakol @RheumNow https://t.co/ZCUXgOr1dH

      David Liew drdavidliew

      3 months ago
      Rheumatoid vasculitis: what to look for and how to find it #EULAR2025 @AshimaMakol @RheumNow https://t.co/ZCUXgOr1dH
      Acute Dactylitis in #Psoriatic_Arthritis

      🔹️1216 patients Canada 🇨🇦
      🔹️52% had at least one episode of a

      Nelly ZIADE 🍀 Nellziade

      3 months ago
      Acute Dactylitis in #Psoriatic_Arthritis 🔹️1216 patients Canada 🇨🇦 🔹️52% had at least one episode of acute dactylitis in a median 12 years 🔹️Positive association with HLA-B27 and HLA-B27/C02 🔹️No association with HLA-B51 #EULAR2025 @RheumNow OP0180 by Kharouf et al. https://t.co/oNNMBcvVb4
      How well do you know this week's rheumatology news?
      Take the rheumIQ quiz
      Take the RheumIQ Quiz

      Podcasts

      • EULAR 2025 Rheumatology RoundUp Hosted by Dr. John J. Cush and Dr. Arthur Kavanaugh
      • EULAR 2025 - Day 9 podcast
      • EULAR 2025 - Day 8 podcast

      Catch up on Conference Podcasts

      ×